| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 20.478 | 70.924 | 89.483 | 108.069 | 130.582 |
| Total Income - EUR | - | - | - | - | - | 20.478 | 110.806 | 89.483 | 108.267 | 130.385 |
| Total Expenses - EUR | - | - | - | - | - | 11.301 | 59.775 | 74.375 | 104.318 | 120.458 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 9.178 | 51.032 | 15.108 | 3.950 | 9.927 |
| Net Profit/Loss - EUR | - | - | - | - | - | 8.973 | 50.322 | 14.347 | 2.923 | 7.263 |
| Employees | - | - | - | - | - | 2 | 5 | 5 | 5 | 4 |
Check the financial reports for the company - Omama Medfie S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 20.734 | 113.073 | 172.264 | 161.068 | 148.953 |
| Current Assets | - | - | - | - | - | 8.919 | 11.500 | 33.278 | 51.577 | 50.441 |
| Inventories | - | - | - | - | - | 1.021 | 7.126 | 27.525 | 38.810 | 47.834 |
| Receivables | - | - | - | - | - | 5.037 | 4.235 | 3.844 | 4.403 | 2.298 |
| Cash | - | - | - | - | - | 2.861 | 138 | 1.908 | 8.364 | 308 |
| Shareholders Funds | - | - | - | - | - | 9.014 | 59.136 | 73.667 | 76.366 | 83.202 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 20.639 | 65.437 | 131.875 | 136.279 | 116.192 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1072 - 1072" | |||||||||
| CAEN Financial Year |
1072
|
|||||||||
Comments - Omama Medfie S.r.l.